206 related articles for article (PubMed ID: 10930425)
21. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
22. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
[TBL] [Abstract][Full Text] [Related]
23. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
Goubin F; Ducommun B
Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
[TBL] [Abstract][Full Text] [Related]
24. p21CDKN1A does not interfere with loading of PCNA at DNA replication sites, but inhibits subsequent binding of DNA polymerase delta at the G1/S phase transition.
Cazzalini O; Perucca P; Riva F; Stivala LA; Bianchi L; Vannini V; Ducommun B; Prosperi E
Cell Cycle; 2003; 2(6):596-603. PubMed ID: 14504476
[TBL] [Abstract][Full Text] [Related]
25. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.
Li KK; Ng IO; Fan ST; Albrecht JH; Yamashita K; Poon RY
Liver; 2002 Jun; 22(3):259-68. PubMed ID: 12100577
[TBL] [Abstract][Full Text] [Related]
26. Association of cyclin A and cdk2 with SV40 DNA in replication initiation complexes is cell cycle dependent.
Cannella D; Roberts JM; Fotedar R
Chromosoma; 1997 Apr; 105(6):349-59. PubMed ID: 9087377
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
28. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
Chen J; Jackson PK; Kirschner MW; Dutta A
Nature; 1995 Mar; 374(6520):386-8. PubMed ID: 7885482
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle-dependent regulation of human DNA polymerase alpha-primase activity by phosphorylation.
Voitenleitner C; Rehfuess C; Hilmes M; O'Rear L; Liao PC; Gage DA; Ott R; Nasheuer HP; Fanning E
Mol Cell Biol; 1999 Jan; 19(1):646-56. PubMed ID: 9858588
[TBL] [Abstract][Full Text] [Related]
31. p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stress-activated kinases.
Medema RH; Klompmaker R; Smits VA; Rijksen G
Oncogene; 1998 Jan; 16(4):431-41. PubMed ID: 9484832
[TBL] [Abstract][Full Text] [Related]
32. Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2, cyclin A and PCNA.
Barboule N; Baldin V; JOzan S; Vidal S; Valette A
Int J Cancer; 1998 Jun; 76(6):891-6. PubMed ID: 9626358
[TBL] [Abstract][Full Text] [Related]
33. Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1.
Adkins JN; Lumb KJ
Biochemistry; 2000 Nov; 39(45):13925-30. PubMed ID: 11076534
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
35. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
36. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
[TBL] [Abstract][Full Text] [Related]
37. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.
Wei GL; Krasinski K; Kearney M; Isner JM; Walsh K; Andrés V
Circ Res; 1997 Mar; 80(3):418-26. PubMed ID: 9048663
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.
Pagano M; Theodoras AM; Tam SW; Draetta GF
Genes Dev; 1994 Jul; 8(14):1627-39. PubMed ID: 7958844
[TBL] [Abstract][Full Text] [Related]
39. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication.
Cardoso MC; Leonhardt H; Nadal-Ginard B
Cell; 1993 Sep; 74(6):979-92. PubMed ID: 8402887
[TBL] [Abstract][Full Text] [Related]
40. Cyclin/cdk2 complexes in the nucleus of HeLa cells.
Jaumot M; Graña X; Giordano A; Reddy PV; Agell N; Bachs O
Biochem Biophys Res Commun; 1994 Sep; 203(3):1527-34. PubMed ID: 7945302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
